title: The impact of hypogammagammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation.
authors.forename: H J
authors.initials: HJ
authors.lastname: Ankersmit
authors.forename: S
authors.initials: S
authors.lastname: Hacker
authors.forename: K
authors.initials: K
authors.lastname: Hoetzenecker
authors.forename: B
authors.initials: B
authors.lastname: Moser
authors.forename: E
authors.initials: E
authors.lastname: Wolner
mesh_terms: D000361:Agammaglobulinemia / Q000150:complications* / Q000209:etiology; D000707:Anaphylaxis / Q000139:chemically induced; D017209:Apoptosis / Q000187:drug effects; D001402:B-Lymphocytes / Q000187:drug effects / Q000378:metabolism; D006353:Heart-Assist Devices / Q000009:adverse effects*; D006801:Humans; D007136:Immunoglobulins / Q000378:metabolism; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D051437:Renal Insufficiency / Q000139:chemically induced; D016896:Treatment Outcome
chemical_list: D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors